コーパス検索結果 (right1)
通し番号をクリックするとPubMedの該当ページを表示します
3 te drug target in an in vivo disease-relevant model system, we introduced a C181S mutation into a conditional NrasG12D "k
6 To account for the patients' different entry times, we introduced a horizontal translation factor to shift each d
7 To account for different entry times among cohorts, we introduced a horizontal translation factor to the dataset
8 ether these gestures were produced to sustain coordination, we introduced a joint test condition in which we simulated a
9 nvasive analysis of DMD gene correction strategies in vivo, we introduced a luciferase reporter in-frame with the C-termi
12 f contacts at a certain position in sequence and structure, we introduced a new metric designated 'contact proximity devi
21 To improve access to ART for incarcerated people with HIV, we introduced a universal test-and-treat (UTT) intervention i
25 between SMARCB1 loss and the process of neural development, we introduced an inducible SMARCB1 loss-of-function system in
27 rial innate immune components that interact with Chlamydia, we introduced C. trachomatis into mouse endometrium via trans
30 In several of our prototype composites, we introduced fluorapatite (FA) crystals, which resemble enam
35 enic as well as antitumor effects, and in the current study we introduced lithium treatment 4 weeks after irradiation.
37 of generating anionic analogues to MN(2) S(2) .Mn(CO)(3) Br we introduced metallodithiolate ligands, MN(2) S(2) (2-) prep
39 To understand how cells deal with ribosome malfunction, we introduced mutations in the Expansion Segment 7 (ES7L) of
43 ne whether miR-125b post-transcriptionally regulates CPSF6, we introduced the 3'UTR of CPSF6 mRNA into a luciferase repor
44 To understand how PRD suppresses lymphomagenesis, we introduced the cancer-associated PRD mutation R3008H (R301
47 s do not respond to ICs in any existing mouse model of SLE, we introduced the FcgammaRIIA (FCGR2A) transgene into the NZB
50 In order to obtain realistic estimates, we introduced two novel protein complex-aware cross-validatio